Physician profile
Armando Yepes
NPI 1710987458
$12,881.46
in general payments reported to CMS, 2019-2025
44 companies · $3,642 in 2025
The $3,642 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,874 · 2020: $400 · 2021: $1,283 · 2022: $1,616 · 2023: $1,205 · 2024: $861 · 2025: $3,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,342 · Travel and Lodging: $1,340 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,342.43 |
| Travel and Lodging | $1,339.92 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,858.05 | 2019-2025 | Perclose Proglide, Esprit, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $1,992.49 | 2019-2024 | Impella |
| Merck Sharp & Dohme LLC | $716.50 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Actelion Pharmaceuticals US, INC. | $562.64 | 2019-2025 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $553.19 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $502.51 | 2019-2023 | |
| Medtronic, INC. | $492.56 | 2021-2025 | Onyx Frontier, Symplicity G3 |
| Heartflow, INC. | $461.98 | 2021-2025 | |
| Pfizer INC. | $452.61 | 2020-2025 | |
| Medtronic Vascular, INC. | $380.01 | 2019 | |
| Amgen INC. | $373.43 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $328.80 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $320.24 | 2019-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $292.13 | 2019-2022 | |
| Edwards Lifesciences Corporation | $291.36 | 2021-2025 | Inspiris Resilia Aortic Valve |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $262.38 | 2024-2025 | Assure Wcd |
| Astellas Pharma US INC | $258.77 | 2019-2021 | |
| Acist Medical Systems, INC. | $173.58 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $172.88 | 2020-2025 | Onpattro, Amvuttra |
| Novo Nordisk INC | $149.35 | 2021-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $146.25 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $142.86 | 2019-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.60 | 2019-2025 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $102.57 | 2021-2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $98.34 | 2022 | |
| Janssen Pharmaceuticals, INC | $75.58 | 2019-2023 | Xarelto |
| Bardy Diagnostics, INC. | $73.40 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $69.92 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $55.04 | 2022-2024 | Nexletol |
| Gilead Sciences, INC. | $52.19 | 2019 | |
| Cardiovascular Systems INC. | $45.92 | 2019 | |
| Recor Medical INC | $45.19 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Biosense Webster, INC. | $38.68 | 2025 | Nuvision Ice Catheter |
| Bard Peripheral Vascular, INC. | $28.19 | 2021 | |
| Baxter Healthcare | $26.86 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $24.62 | 2020 | |
| Shockwave Medical, INC | $22.53 | 2019 | |
| Integra Lifesciences Corporation | $22.51 | 2023 | Codman Certas, Cusa Clarity, Duraseal Exact Spinal Sealant System |
| Inspire Medical Systems, INC. | $21.92 | 2023 | Inspire |
| Lexicon Pharmaceuticals, INC. | $20.25 | 2023 | Inpefa |
| Vital Connect, INC | $15.97 | 2025 | Vitalpatch Rtm |
| G Medical Diagnostic Services, INC. | $13.99 | 2022 | |
| Chiesi USA, INC. | $13.84 | 2019 | |
| Tactile Systems Technology INC | $12.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Yepes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.